Abstract
Objective:Visinin-like protein 1 (VILIP-1) is a neuron-specific calcium sensor protein rapidly released into blood after mild traumatic brain injury (mTBI) and may be a suitable biomarker for identification of sports-related concussion (SRC). The objective of the study is to test if quantification of a specific post-translationally modified (ubiquitinated) form of VILIP-1 (ubVILIP-1) from a fingerstick blood sample using a point of care (POC) lateral flow device (LFD) can be used to rapidly identify athletes with SRC.Design:Prospective cohort study.Setting:Side-line blood collection at football, soccer, and volleyball games/practices.Participants:Division I athletes with/without SRC.Main Outcome Measures:Blood ubVILIP-1 concentrations.Results:Data collected over 2 athletic seasons from non-SRC athletes (controls) show a small but statistically significant elevation of ubVILIP-1 over an individual season for male athletes (P = 0.02) dependent on sport (P = 0.014) and no significant changes in ubVILIP-1 levels between seasons. For SRC athletes, the data show ubVILIP-1 levels substantially increase above baseline as soon as 30 minutes postdiagnosis with peak concentrations and times postinjury that vary based on injury severity.Conclusion:Results of the study suggest quantification of blood ubVILIP-1 levels measured using an LFD may provide an objective identification of athletes with SRC, setting the stage for further study with a larger number of SRC patients.
Original language | English |
---|---|
Pages (from-to) | 623-626 |
Number of pages | 4 |
Journal | Clinical Journal of Sport Medicine |
Volume | 32 |
Issue number | 6 |
DOIs | |
State | Published - Nov 1 2022 |
Bibliographical note
Publisher Copyright:© 2022 Lippincott Williams and Wilkins. All rights reserved.
Keywords
- biomarkers
- concussion
- lateral flow device
- sport-related
- traumatic brain injury
- ubiquitinated VILIP-1
ASJC Scopus subject areas
- Orthopedics and Sports Medicine
- Physical Therapy, Sports Therapy and Rehabilitation